Cutting Edge: C3d Functions as a Molecular Adjuvant in the Absence of CD21/35 Expression

Journal of Immunology

Volumn 172, Issue 10, 2004, Pages 5833-5837

  Haas, Karen M ^a   Toapanta, Franklin R ^b   Oliver, Julie A ^a   Poe, Jonathan C ^a   Weis, John H ^c   Karp, David R ^d   Bower, Joseph F ^b   Ross, Ted M ^b   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; GLYCOPROTEIN GP 120; IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; PLASMID DNA; RECOMBINANT PROTEIN; STREPTAVIDIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; COVALENT BOND; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 2442479554     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.10.5833     Document Type: Article

References (31)

1. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Caroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
2. Molina, H., V. M. Holers, B. Li, Y.-F. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad Sci. USA 93:3357.
3. Haas, K. M., M. Hasegawa, D. A. Steeber, J. C. Poe, M. D. Zabel, C. B. Bock, D. R. Karp, D. E. Briles, J. H. Weis, and T. F. Tedder. 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17:713.
4. Botto, M., and M. J. Walport. 1993. Hereditary deficiency of C3 in animals and humans. Int. Rev. Immunol. 10:37.
5. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549.
6. Wessels, M. R., P. Butko, M. Ma, H. B. Warren, A. Lage, and M. C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Nat. Acad Sci. USA 92:11490.
7. Ochsenbein, A. F., D. D. Pinschewer, B. Odermatt, M. C. Carroll, H. Hengartner, and R. M. Zinkernagel. 1999. Protective T cell-independent antiviral antibody responses are dependent on complement. J. Exp. Med. 190:1165.
8. Dempsey, P. W., M. E. D. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
9. Ross, T. M., Y. Xu, T. D. Green, D. C. Montefiori, and H. L. Robinson. 2001. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res. Hum. Retroviruses 17:829.
10. Green, T. D., D. C. Montefiori, and T. M. Ross. 2003. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J. Virol. 77:2046.
11. Mitchell, J. A., T. D. Green, R. A. Bright, and T. M. Ross. 2003. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 21:902.
12. Green, T. D., B. R. Newton, P. Rota, Y. Xu, H. L. Robinson, and T. M. Ross. 2002. Immune responses in mice to measles hemagglutin-C3d DNA vaccinations. Vaccine 20:242.
13. Ross, T. M., Y. Xu, R. A. Bright, and H. L. Robinson. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza challenge. Nat. Immunol. 1:127.
14. Test, S. T., J. Mitsuyoshi, C. C. Connolly, and A. H. Lucas. 2001. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect. Immun. 69:3031.
15. Tedder, T. F., L.-J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15:437.
16. Poe, J. C., M. Hasegawa, and T. F. Tedder. 2001. CD19, CD21 and CD22: multi-faceted response regulators of B lymphocyte signal transduction. Int. Rev. Immunol. 20:739.
17. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder. 2001. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol 167:3190.
18. Henson, S. E., D. Smith, S. A. Boackle, V. M. Holers, and D. R. Karp. 2001. Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J. Immunol. Methods 258:97.
19. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105.
20. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
21. Fingeroth, J. D., M. A. Benedict, D. N. Levy, and J. L. Strominger. 1989. Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. USA 86:242.
22. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response to a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
23. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppress antibody responses in vivo. J. Immunol. 147:224.
24. Wiersma, E., T. Kinoshita, and B. Heyman. 1991. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur. J. Immunol 21:2501.
25. Chakravarty, L., M. D. Zabel, J. J. Weis, and J. H. Weis. 2002. Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 14:139.
26. van Noesel, C. J. M., A. C. Lankester, and R. A. W. van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today 14:8.
27. Bennett, M., and T. Leanderson. 2003. Was it there all the time? Scand J. Immunol. 57:499.
28. Quigg, R. J., J. J. Alexander, C. F. Lo, A. Lim, C. He, and V. M. Holers. 1997. Characterization of C3-binding proteins on mouse neutrophils and platelets. J. Immunol. 159:2438.
29. Inada, S., E. J. Brown, T. A. Gaither, C. H. Hammer, T. Takahashi, and M. M. Frank. 1983. C3d receptors are expressed on human monocytes after in vitro cultivation. Proc. Natl. Acad. Sci. USA 80:2351.
30. Vik, D. P., and D. T. Fearon. 1985. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3. J. Immunol. 134:2571.
31. Hellwage, J., T. S. Jokiranta, M. A. Friese, T. U. Wolk, E. Kampen, P. F. Zipfel, and S. Meri. 2002. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J. Immunol. 169:6935.